Myasthenia gravis: Efficacy of potential therapy for autoimmune disorder of muscle weakness

A fast-acting 'vaccine' has been developed that can reverse the course of myasthenia gravis, a non-inherited autoimmune form of muscle weakness, in an animal model of the disease. Nearly 60,000 Americans suffer from myasthenia gravis, and the disease has no cure at this time.